News - Radboudumc

html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

Research Departments Pulmonary Diseases News

News items related to the Department of Pulmonary Diseases.

Tuberculosis medication safe in higher dosage

28 March 2019

For more than 40 years, patients with tuberculosis have been prescribed almost the same dose of rifampicin. Some studies suggest that the dose is too low and not optimal.

The potential for shortening tuberculosis treatment with higher rifampicin doses

5 July 2018

In Clinical Infectious Diseases Elin Svensson and colleagues showed that increasing rifampicin exposure shortened the time needed to reach undetectable levels of bacteria in sputum.

Tuberculosis research Martin Boeree on Euronews

7 December 2017

One of the Sustainable Development Goals is a world without tuberculosis in 2030.

Go to
mijnRadboud

This website uses cookies.

Filter results

Tuberculosis medication safe in higher dosage

The potential for shortening tuberculosis treatment with higher rifampicin doses

Tuberculosis research Martin Boeree on Euronews